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Abstract
Background: Gastroesophageal reflux disease (GERD) has become a major health problem globally, affecting
patients’ health-related quality of life (HRQOL). Barrett’s esophagus (BE) is a precancerous lesion associated with
GERD. BE patients might not only suffer from HRQOL losses by GERD but also face psychological distress due to the
increased risk of developing cancer. However, the majority of patients in Asia have shorter BE segment which is
different from the West. This study aimed to determine whether the HRQOL in BE patients were worse than in
healthy referents in Taiwan.
Methods: Patients who received referral esophagogastroduodenoscopy for various symptoms were evaluated for
the existence of BE. Lesions were judged as endoscopically suspected esophageal metaplasia (ESEM) if they showed
morphological resemblances to BE by endoscopy. The diagnosis of BE was confirmed by histology with intestinal
metaplasia or gastric metaplasia based on the Montreal definition. The World Health Organization Quality of Life
(WHOQOL-BREF) was administered to BE patients before treatment. For each BE patient, we selected 2 age-, sex-,
educational background and municipality-matched healthy referents, sampled by simple randomization method
from a national survey in Taiwan. Multiple linear regression models were constructed to control the potential
confounders.
Results: A total of 84 patients diagnosed with BE were enrolled as BE group and then compared with 168 healthy
referents. The BE group had significantly lower WHOQOL-BREF scores than those of healthy referents in the physical
domain (P < 0.05) but higher scores in the environment domain (P < 0.05). In the physical domain, the BE group
had significantly lower scores in various facets, including pain, discomfort, sleep and rest and dependence on
medications or treatments. There was no significant difference in social and psychological domains between the BE
group and healthy referents.
Conclusions: BE patients suffer from poor sleep and rest and high dependence on medications, which significantly
reduce their quality of life. Individual facets of each domain warrants a better clinical healthcare to improve quality
of life of BE patients.
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Background
Gastroesophageal reflux disease (GERD) has become a
major health problem globally [1–4]. Patients with
GERD usually suffer from various symptoms, including
heart burn, acid regurgitation, epigastralgia, non-cardiac
chest pain, chronic cough, asthma and hoarseness.
Nighttime acid regurgitation symptoms may interfere
with sleep. Therefore, patients with GERD may experi-
ence losses on their health-related quality of life
(HRQOL) compared with the healthy population [5–7].
Barrett’s esophagus (BE) involves intestinal metaplastic
changes of esophageal squamous mucosa, which is
regarded as a precancerous lesion of esophageal adeno-
carcinoma [8]. The development of BE is associated with
GERD [9]. The reported prevalence of BE in Western
countries varied from 6.3 to 13.6% in patients with
GERD [5, 10–12].
Patients with BE often share similar symptoms as pa-
tients with GERD [8, 13]. These symptoms could affect
their HRQOL [14–19]. Patients who experienced a lon-
ger duration of GERD symptoms or higher grade of ero-
sive reflux disease (ERD) had higher risk of developing
BE [3, 10, 20–22]. However, 17–40% of BE subjects
didn’t report reflux symptoms [3, 23–25]. The difference
of QOL between GERD patients and BE patients re-
mains inconsistent. Some studies indicated no significant
difference between these two groups [16, 17]. In con-
trast, Lippmann et al. found that BE patients have better
HRQOL than patients with non-erosive reflux disease
(NERD) or ERD [15]. This difference is only partially at-
tributable to fewer severe symptoms among BE patients.
Under the stress of increased cancer risks, BE subjects
might present with a poorer score of QOL in psycho-
logical domain. However, psychological distress did not
seem to differ significantly between GERD and BE pa-
tients [15]. Gerson et al. did not detect a significant dif-
ference in time-trade off (TTO) utility values based on
heartburn symptoms or annual risk of cancer in patients
with non-dysplastic BE [18]. However, TTO utility values
are significantly lower for BE subjects with increasing
cancer risks such as BE patients with lower-grade dys-
plasia or high-grade dysplasia.
To have a fair determination of QOL in BE patients,
we should compare them with a healthy representative
referents and control of potential confounders. However,
few previous studies of the QOL of BE patients could
fulfill these criteria. Moreover, QOL should cover not
only physical and psychological health but also social
and environmental status (e.g., home environment, so-
cial support, financial resource and transport). In 1991,
the World Health Organization initiated a project to de-
velop a generic and standardized QOL instrument sim-
ultaneously in many countries, which led to the World
Health Organization Quality of Life (WHOQOL)
instrument [26]. The WHOQOL has two unique fea-
tures. First, it encompasses physical, psychological, social
and environment domains. Second, it is a cross-cultural
instrument developed for use across different patient
groups in different countries [27]. The WHOQOL
Group further developed a simplified questionnaire,
called the WHOQOL-BREF [28]. The WHOQOL-BREF
is also a sensitive tool to evaluate HRQOL of patients
with different diseases [29–31].
Considering that most Asian patients have shorter BE
segment compared to patients in Western countries, this
study aimed to determine whether HRQOL of BE pa-
tients were worse than healthy referents in the ethnic




Patients who received esophagogastroduodenoscopies
(EGD) at E-Da Hospital from April 1, 2009 to March 31,
2012 were recruited into this study.. Lesions were judged
as endoscopically suspected esophageal metaplasia
(ESEM) if they showed morphological resemblances to
BE by endoscopy [32]. The circumference and maximum
diameter of BE were rated according to the Prague C
and M criteria. The length of BE less than 3 cm was de-
fined as short segment BE. A standardized endoscopic
biopsy protocol (i.e., a random biopsy from four quad-
rants, every 2 cm) was performed at sites with ESEM.
The diagnosis of BE was confirmed by histology based
on the Montreal definition and classification [32]. All
patients with newly diagnosis BE were enrolled in this
study. Body weight and height were recorded. The pres-
ence of diabetes, hypertension, heart disease, cancer and
other major diseases, as well as education level, marital
status, employment, religion, monthly income and his-
tories of smoking or drinking were recorded. The Insti-
tutional Ethics Committee of E-Da Hospital approved
this study (EMRP-098-093).
HRQOL questionnaire
All subjects were asked to complete a validated generic
QOL questionnaire (WHOQOL-BREF, Taiwan version)
in the outpatient clinic prior to medical treatment. The
Taiwan version of the WHOQOL-BREF contains four
domains (physical, psychological, social and environ-
ment), including the 26 original items of the
WHOQOL-BREF, plus two culture-specific questions.
One item addressing “respect from others” was catego-
rized into the social domain, and another corresponded
to “eating what one likes to eat” and was categorized to
the environment domain. The method of application,
the scoring procedures and reference time point (during
the last 2 weeks) were the same as the original
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WHOQOL-BREF [28]. In brief, each item was scored
from 1 to 5 points, and a higher score was considered a
better QOL. Because the numbers of items are different
for each domain, the domain scores were calculated by
multiplying the average scores of all items in the domain
by a factor of 4. Therefore, each domain score would
have the same range, from 4 to 20.
Reference population
A reference group with sex, age (within 3 years), munici-
pality, marriage and education background-matched
healthy subjects was randomly sampled from the data-
base of 2001 National Health Interview Survey (NHIS)
conducted by the National Health Research Institute and
the Bureau of Health Promotion, Department of Health,
Taiwan [33]. The 2001 NHIS was intended to provide
nationwide estimates on health conditions, health behav-
iors and distribution of medical resources for the
Taiwanese population. The WHOQOL-BREF, Taiwan
version, was one of the tools included in this national
survey program. In total, 27,160 eligible persons living in
7357 households were selected through multi-stage
sampling proportional to household population size in
January 2001. This data is very unique in that it is
considered representative of the national population
in terms of age, sex and urbanization index. In our
study, each BE patient was matched with two refer-
ence subjects from the national sample.
Statistical analysis
We conducted a descriptive analysis to compare the
demographic characteristics and each domain of WHO-
QOL between BE patients and reference subjects using
T-test.. We further used multiple linear regression
models to estimate the summary scores of each domain
and individual items as dependent variables, while the
presence of BE, BE with dysplasia, BE length, age, sex,
years of education, employment, monthly income, mari-
tal status, smoking and alcohol drinking were included
as the independent predictive variables. A forward step-
wise strategy was applied to select significant independ-
ent variables with P < 0.05 as the inclusion criterion. All
data were collected and analyzed using SAS version 9.2.
Results
A total of 84 BE patients were diagnosed by EGD and
histological confirmation during the study period.
Among these BE patients, 56 (66.7%) reported GERD
associated symptoms, 51 (60.7%) were diagnosed as ero-
sive esophagitis, 68 (81.0%) had short segment BE, and
only 7 (8.3%) had low-grade dysplasia.
Table 1 shows the demographic and clinical character-
istics of 84 patients with BE and 168 matched healthy
referents. The mean age of BE patients was 54.1 years
and 82.1% of them were male. Compared to healthy
subjects, BE patients had higher prevalence of smoking
and drinking and higher body mass index (BMI).
Multiple linear regression analysis of HRQOL scores in BE
patients and healthy subjects
To improve statistical efficiency, the educational status
was classified as higher educational background
(>12 years) and lower educational background
(≤12 years). Low socio-economic status was defined as
subjects with monthly income less than 667 US dollars.
Results of multiple regression analysis for different
Table 1 Demographic characteristics and domain scores of patients with Barrett’s esophagus, and age-, sex-, municipality-, marriage-
and education-matched healthy referents
Characteristics Barrett’s esophagus (n = 84) Healthy referents (n = 168) P Value
Sex (% male) 82.14 82.14 1.0
Age (mean ± SD) 54.11 ± 14.29 53.17 ± 14.36 0.98
% Married 80.95 77.38 0.52
% Education (>12 years) 22.62 22.02 0.92
% Employment 83.33 74.07 0.11
% Smoking* 36.90 22.96 0.03
% Drinking* 57.14 22.96 <0.001
BMI (kg/m2) (mean ± SD) * 25.42 ± 3.42 22.44 ± 2.91 <0.001
Q1 overall QOL* 3.15 ± 0.80 3.36 ± 0.63 0.028
Q2 overall health* 2.92 ± 0.84 3.57 ± 0.69 <0.001
Physical* 12.42 ± 1.57 15.14 ± 2.42 <0.001
Psychological 13.44 ± 1.86 13.67 ± 2.27 0.43
Social 14.45 ± 2.11 14.22 ± 2.41 0.45
Environment* 14.53 ± 2.04 13.71 ± 2.31 0.006
* P < 0.05
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domain scores of WHOQOL-BREF showed that BE pa-
tients had lower scores in the physical domains and
higher scores in the environment domain (Table 1).
However, QOL scores in the psychological and social
domain were similar between the two groups. BE pa-
tients had lower scores of overall QOL and health than
the healthy referents. Marriage was the major factor as-
sociated with increased HRQOL scores (Table 2). Higher
educational background and high age were associated
with increased scores in the environment domain.
Multiple linear regression analysis of HRQOL scores in
facets of each domain
Table 3 summarizes results of multiple linear regression
analysis of HRQOL scores in facets of each domain, after
adjusting for potential confounding factors. In the phys-
ical domain, BE patients had significantly lower scores in
pain and discomfort, sleep and rest and dependence on
medication or treatments. In the environment domain,
BE patients also had higher scores in various facets, in-
cluding financial resources, physical safety and security,
home environment, health and social care, physical en-
vironment, opportunities for acquiring new information
and skills, transport and eating.
We found that marriage was associated with higher
HRQOL scores in facets of mobility, activities of daily
living, spirituality/religion/personal beliefs, social sup-
port and sexual activity, opportunities for acquiring new
information and skills, and eating. A higher education
level was associated with higher HRQOL scores in facets
of mobility, working capacity, financial resources, oppor-
tunities for acquiring new information and skills, partici-
pation in and opportunities for the recreation or leisure,
and transport. In the environment domain, higher age
was associated with higher HRQOL scores in facets of fi-
nancial resources, physical safety and security, home
environment, physical environment, participation in &
opportunities for recreation or leisure and transport.
Discussion
Although many studies [14–18] reported significantly
lower scores of QOL among BE patients, none of them
controlled for potential confounding factors comprehen-
sively. Most studies focused on the difference of QOL
between patients with GERD and BE [15–18] but lacked
a comparison with normal population. Eloubeidi et al.
[17] conducted a prospective study to compare the
HRQOL between BE and GERD patients but didn’t find
significant difference between these two groups. A gen-
eric QOL questionnaire, SF-36, was applied to test the
difference between the GERD, BE subjects and age-
matched normal referents from the U.S. Patients with
GERD or BE had lower QOL scores in all subscales of
SF-36 than the general US population. Kuliq et al. [16]
compared the HRQOL among patients with NERD, ERD
and BE using a prospective cohort study design, but
didn’t find significant difference among these three
groups. However, all of them had lower QOL scores of
SF-36 than the age and gender-matched normal refer-
ents in Germany. However, neither Eloubeidi nor Kuliq’s
studies controlled potential confounders. Multiple linear
regression model has been applied by various QOL re-
lated researches to control confounding factors [34–36].
As age, sex, marriage, drinking, smoking, BMI and edu-
cation could partially explain variations of scores of
items and domains of WHOQOL (Tables 2 and 3), these
factors might potentially confound the findings of previ-
ous studies. Furthermore, the referents sampled from
the US and German studies did not represent the na-
tionwide population. Therefore, the difference between
BE and normal population was still un-settled.
Table 2 Significant regression coefficients and standard error (in parentheses) based on multiple linear regression analysis of HRQOL
and determinants in patients with Barrett’s esophagus, and age-, sex-, municipality-, marriage- and education-matched healthy
referents
Physical Psychological Social Environment
Constant 14.58** (0.33) 12.81** (0.32) 13.40** (0.35) 11.12** (0.64)
BE (yes/no) −1.78** (0.22) - - 1.01** (0.29)
Marriage (yes/no) 0.65* (0.33) 0.94* (0.36) 1.11* (0.39) -
Age (year) - - - 0.042** (0.012)
Education (>12 years/≤12 years) - - - 0.81* (0.35)
Sex (female/male) - - - -
Employment (yes/no) - - - -
Drinking (yes/no) - - - -
Smoking (yes/no) - - - -
BMI (kg/m2) - - - -
* P < 0.05; ** P < 0.005
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Table 3 Regression coefficients and standard error (in parentheses) based on multiple linear regression analysis of each facet of HRQOL in patients with Barrett’s esophagus, and
age-, sex-, municipality-, marriage- and education-matched healthy referents
Domains Facets BE (yes/no) Age (year) Sex (female/male) Marriage (yes/no) Drinking (yes/no) Smoking (yes/no) BMI (kg/m2) Education (>12/
≤12 years)
Physical Pain and discomfort −1.81** (0.12) - - - 0.32* (0.14) −0.31* (0.14) - -
Energy and fatigue - 0.0093* (0.0046) −0.39* (0.14) - - - - -
Sleep and rest −0.72** (0.13) - - - - - - -
Mobility - - - 0.38* (0.13) - - - 0.27* (0.13)
Activities of daily living - - −0.28* (0.12) 0.25* (0.12) - - - -
Dependence on medication
or treatments
−2.31** (0.13) - - - - - - -
Working capacity - - - - - - - 0.27* (0.11)
Psychological Thinking, learning, memory
& concentration
- 0.0097* (0.0048) −0.45* (0.15) - - - - -
Self-esteem - - −0.28* (0.12) - - - - -
Body image & appearance - - −0.30* (0.15) - −1.32** (0.20) −1.35** (0.12) - -
Negative feelings −0.89** (0.12) −0.0098* (0.0049) - - - - - -
Positive feelings 0.27* (0.12) - - - - - - -
Spirituality/religion/personal
beliefs)
0.32* (0.12) - - 0.45** (0.15) - - - -
Social Social support - - −0.23* (0.11) 0.25 (0.11) - - −0.030* (0.014) -
Personal relationships 0.21* (0.10) - - - - - - -
Sexual activity - −0.0096* (0.0041) - 0.63** (0.13) - - −0.032* (0.014) -
Being respected & accepted - - −0.25* (0.12) - - - - -
Environment Financial resources 0.29* (0.13) 0.014* (0.0055) - - - - - 0.46** (0.16)
Physical safety and security 0.29* (0.11) 0.011* (0.0042) - - - - - -
Home environment 0.24* (0.10) 0.013** (0.0037) - - - - - -
Health and social care: availability
and quality
0.35** (0.092) - - - - - - -
Physical environment 0.27* (0.12) 0.018** (0.0048) −0.29* (0.15) - - - - -
Opportunities for acquiring new
information and skills
0.33* (0.13) - - 0.30* (0.15) - - −0.037* (0.019) 0.45** (0.14)
Participation in & opportunities
for recreation or leisure
- 0.015* (0.0057) - - - - - 0.41* (0.17)
Transport 0.28** (0.092) 0.0088* (0.0038) - - - - - 0.27* (0.11)
Eating 0.38** (0.10) - - - - −0.24* (0.11) - -



















To our knowledge, our study is the first one which in-
cluded nation-wide healthy referents and also adjusted
for potential confounding factors, including age, sex,
education, municipality and marriage. In particular, the
healthy referents were randomly sampled from a nation-
wide population in Taiwan. The WHOQOL-BREF was
one of tools in this survey. After controlling for potential
confounding factors, we have demonstrated that BE pa-
tients suffered from poor QOL in physical domain and
its associated various facets, but higher QOL scores in
environment domain and its associated facets (Tables 2
and 3). The psychological and social domains were not
affected by BE. Case-control study is an important
method to find the difference between patients with spe-
cific disease and healthy group. However, QOL could be
influenced by different culture, region and country. There-
fore, the inclusion of a nation-wide healthy subjects as our
control group is the strength of this study. Some of QOL
studies for variable diseases from Asia use nation-wide
healthy referents, such as irritable bowel syndrome by
Jamali et al., epilepsy by Liou et al. [34], lung cancer by
Lee et al. [37, 38], obesity by Chang et al. [30].
Previous studies on HRQOL of BE patients reported
the negative impacts on physical and mental scales based
on the SF-36 [16, 17], which is a generic instrument. We
administered the WHOQOL-BREF in this study, which
is also a generic QOL questionnaire with coverage ex-
tended to items of social, and environment domains. In
the physical domain, BE subjects had poorer QOL in
facets of pain and discomfort, sleep and rest and de-
pendence on medication or treatments. These affected
facets make sense empirically and can raise attention in
clinical practice when treating BE patients. Our finding
that BE patients had higher QOL scores in environment
domain were consistent with a previous HRQOL study
[37]. In Taiwan, patients with some major chronic dis-
eases can access medical treatment easily owing to its
high coverage of National Health Insurance. For BE pa-
tients in Taiwan, medical treatment, such as proton
pump inhibitor and regular EGD surveillance, have been
covered by the national insurance. In addition, BE asso-
ciated information can be easily acquired by patients
from health system or media. Therefore, higher QOL
scores were reported in many facets of the environment
domain, such as financial resources, physical safety and
security, home environment, health and social care,
physical environment, transport, opportunities for ac-
quiring new information and skills, etc.
The WHOQOL-BREF encompasses physical, psycho-
logical, social and environment domains and various
facets associated with each domain. It is a generic ques-
tionnaire covering broad fields of QOL. Our study re-
vealed the patients with BE in Taiwan had poor HRQOL
in physical domain but better in environment domain.
WHOQOL-BREF is a sensitive tool to evaluate HRQOL
for patients with different diseases, such as diabetes melli-
tus [39], tuberculosis [40], lung cancer [37], inflammatory
bowel disease [41], irritable bowel syndrome [42, 43], mor-
bid obesity [30, 35, 44], epilepsy [34], heroin-dependent
patients [45] and traumatic limb injury [46]. It is not only
useful to compare the difference of HRQOL between
cases and controls [34, 35, 38, 42] or subgroups with dif-
ferent severity [35] but also serves as a standard index in
validation study for other disease-specific questionnaire
[39, 40, 44, 46]. Therefore, WHOQOL-BREF has become
an important questionnaire in QOL researches.
Conclusions
The HRQOL for BE patients in Taiwan had poorer qual-
ity of life in the physical domain but better quality of life
in the environment domain, compared to the general
population. Healthcare professionals can refer to individ-
ual facets of each domain for a better clinical healthcare
and management for quality of life of BE patients.
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